Keyphrases
Solid Tumors
100%
Technetium-99m
100%
Folate Receptor
100%
EC20
100%
Immunohistochemistry
23%
Tumor
23%
Immunohistochemical Analysis
15%
Confidence Interval
7%
Whole-body
7%
Renal Cell Carcinoma
7%
Single-photon Emission Computed Tomography (SPECT)
7%
In Vivo Imaging
7%
Tissue Sampling
7%
After Injection
7%
Patient Selection
7%
Tumor Tissue
7%
Suspected Cancer
7%
Same Patient
7%
Advanced Cancer
7%
Disease Stage
7%
Metastatic Lesions
7%
Vitamins
7%
Epithelial Cancer
7%
Subsequent Surgery
7%
Prior Surgery
7%
Scintigraphy
7%
Receptor Targeted Imaging
7%
Planar Images
7%
Folate Receptor Expression
7%
Targeted Imaging Agents
7%
Index Lesion
7%
Receptor-targeted Therapy
7%
Non-invasive Procedure
7%
Folate Conjugate
7%
Heterogeneous Expression
7%
Medicine and Dentistry
Solid Malignant Neoplasm
100%
Technetium-99
100%
Folate Receptor
100%
Immunohistochemistry
38%
Neoplasm
30%
Malignant Neoplasm
15%
Clear Cell Renal Cell Carcinoma
7%
Single-Photon Emission Computed Tomography
7%
In Vitro
7%
Disease
7%
Biopsy
7%
Targeted Therapy
7%
Imaging Agent
7%
Advanced Cancer
7%
Scintigraphy
7%
Non Invasive Procedure
7%
Receptor Expression
7%
Folic Acid
7%
Tissue Sampling
7%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
100%
Technetium 99m
100%
Folate Receptor
100%
Neoplasm
30%
Malignant Neoplasm
15%
Disease
7%
Renal Cell Carcinoma
7%
Folic Acid
7%
Advanced Cancer
7%
Neuroscience
Technetium-99m
100%
Folate Receptor
100%
Immunohistochemistry
38%
In Vivo
15%
In Vitro
7%
Receptor Expression
7%
Single-Photon Emission Computed Tomography
7%
Folic Acid
7%
Folate
7%